Indication
Acquired immunodeficiency syndrome with toxoplasmosis
Acquired immunodeficiency syndrome with toxoplasmosis refers to a life-threatening opportunistic infection caused by the intracellular protozoan parasite *Toxoplasma gondii* in individuals with advanced human immunodeficiency virus (HIV) disease. Read more about Acquired immunodeficiency syndrome with toxoplasmosis
13 drugs 13 manufacturers
Drugs that treat it
Common Acquired immunodeficiency syndrome with toxoplasmosis therapies.
SULFADIAZINE
DARAPRIM (pyrimethamine)
DARAPRIM (pyrimethamine)
DARAPRIM (pyrimethamine)
DARAPRIM (pyrimethamine)
DARAPRIM (pyrimethamine)
PYRIMETHAMINE
SULFADIAZINE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcquired immunodeficiency syndrome with toxoplasmosis refers to a life-threatening opportunistic infection caused by the intracellular protozoan parasite *Toxoplasma gondii* in individuals with advanced human immunodeficiency virus (HIV) disease.
It occurs primarily in severely immunocompromised patients, most commonly when CD4 T-lymphocyte counts decline below 100 to 200 cells/µL, triggering the reactivation of latent tissue cysts.
The disease predominantly targets the central nervous system as toxoplasmic encephalitis, characterized by necrotizing focal brain lesions that manifest with headaches, altered mental status, seizures, and focal neurological deficits, although disseminated, pulmonary, or ocular involvement may also occur.
- nih.gov
Acquired immunodeficiency syndrome with toxoplasmosis refers to a life-threatening opportunistic infection caused by the intracellular protozoan parasite *Toxoplasma gondii* in individuals with advanced human immunodeficiency virus (HIV) disease
- nih.gov
Acquired immunodeficiency syndrome with toxoplasmosis refers to a life-threatening opportunistic infection caused by the intracellular protozoan parasite *Toxoplasma gondii* in individuals with advanced human immunodeficiency virus (HIV) disease The disease predominantly targets the central nervous system as toxoplasmic encephalitis, characterized by necrotizing focal brain lesions that manifest with headaches, altered mental status, seizures, and focal neurological deficits, although disseminat...
- hiv.gov
It occurs primarily in severely immunocompromised patients, most commonly when CD4 T-lymphocyte counts decline below 100 to 200 cells/µL, triggering the reactivation of latent tissue cysts The disease predominantly targets the central nervous system as toxoplasmic encephalitis, characterized by necrotizing focal brain lesions that manifest with headaches, altered mental status, seizures, and focal neurological deficits, although disseminated, pulmonary, or ocular involvement may also occur
- nih.gov
It occurs primarily in severely immunocompromised patients, most commonly when CD4 T-lymphocyte counts decline below 100 to 200 cells/µL, triggering the reactivation of latent tissue cysts
Personalize your experience
Follow Acquired immunodeficiency syndrome with toxoplasmosis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.